Reactions 1704, p184 - 2 Jun 2018 Thrombocytopenia: case report In a prospective, observational, non-invasive post-market clinical follow-up study involving 12 adult patients, one adult patient [age and sex not stated] was described, who developed heparin-induced thrombocytopenia following treatment with heparin [route not stated; not all dosages stated]. The patient, who had biventricular heart failure, was scheduled to undergo EXCOR adult pumps implantation. The implantation procedure was performed on cardiopulmonary bypass. The patient received heparin 300 U/kg along with standard cannulation to the distal ascending aorta and bicaval venous cannulation. After implantation of EXCOR pump, patient was administered protamine sulfate [protamine] to antagonize heparin completely. Post-operatively, within a period of 24 hours, the patient started receiving anticoagulant treatment with heparin [unfractionated heparin]. Additionally, the patient was treated with unspecified vitamin K antagonists. Low molecular weight heparin was then administered to bridge for long term. However, the patient developed heparin- induced thrombocytopenia. Further, on post-operative day (POD) 22, the patient developed arterial cerebral thromboembolism with a need for craniotomy for a bleed. On POD 108, the patient developed ischaemic cerebrovascular accidents followed by a non-cerebral thromboembolism. Later, the patient underwent multiple pump replacements because of deposits. On POD 212, the patient underwent heart transplantation [duration of treatment to reaction onset and outcome not stated]. Author comment: "One patient’s post-implantation period was complicated by heparin-induced thrombocytopenia." Schmack B, et al. Successful support of biventricular heart failure patients by new EXCOR Adult pumps with bileaflet valves: a prospective study. Clinical Research in Cardiology 107: 413-420, No. 5, May 2018. Available from: URL: http:// doi.org/10.1007/s00392-017-1200-4 - Germany 803322896 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704
Reactions Weekly – Springer Journals
Published: Jun 2, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera